YU12991A - Rekombinantne vakcine protiv kokcidioze-5-7 eimeria površinski antigen - Google Patents
Rekombinantne vakcine protiv kokcidioze-5-7 eimeria površinski antigenInfo
- Publication number
- YU12991A YU12991A YU12991A YU12991A YU12991A YU 12991 A YU12991 A YU 12991A YU 12991 A YU12991 A YU 12991A YU 12991 A YU12991 A YU 12991A YU 12991 A YU12991 A YU 12991A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- surface antigen
- proteins
- eimeria
- fragments
- recombinant
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 5
- 102000036639 antigens Human genes 0.000 title abstract 5
- 108091007433 antigens Proteins 0.000 title abstract 5
- 241000223924 Eimeria Species 0.000 title abstract 4
- 208000003495 Coccidiosis Diseases 0.000 title abstract 3
- 206010023076 Isosporiasis Diseases 0.000 title abstract 3
- 108010008038 Synthetic Vaccines Proteins 0.000 title abstract 2
- 229940124551 recombinant vaccine Drugs 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 102000004169 proteins and genes Human genes 0.000 abstract 7
- 241000700605 Viruses Species 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 3
- 239000002243 precursor Substances 0.000 abstract 3
- 101710203310 Apical membrane antigen 1 Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 238000004458 analytical method Methods 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000144977 poultry Species 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
- 239000013603 viral vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
REKOMBINANTNE VAKCINE PROTIV KOKCIDIOZE-5-7 EIMERIA POVRŠINSKI ANTIGEN. Ovaj pronalazak omogućava dobijanje DNK koja kodira protein-prekursor površinskog antigena merozoita Eimeria-e, pri čemu površinski antigen ima vidljivu molekulsku težinu od oko 23 kilodaltona, utvrdjenu analizom SDS PAGE. Polazeći od ove DNK, mogu se proizvesti proteini koji imaju jednu ili više imunoreaktivnih i/ili antigenih determinanti pomenutog površinskog antigena, kao i rekombinantni vektori i rekombinantni virusi koji sadrže pomenutu DNK ili njene fragmente, i transformisane mikroorganizme koji sadrže takve vektore i viruse. Prema tome, ovaj pronalazak odnosi se na postupke za proizvodnju pomenutih proteina i transformisanih mikroorganizama. Ovaj predmet takodje se odnosi na prečišćeni površinski antigen od 23 kDa merozoita sam po sebi, i na njegov prekursorski oblik od 30 kDa sam po sebi, kao i na postupke za zaštitu živine od kokcidioze koristeći površinski antigen Eimeria-e, protein-prekursor i/ili njegove fragmente. Proteini i fragmenti iz ovog pronalaska mogu se aplicirati radi takve zaštite bilo kao prečišćeni proteini bilo u obliku DNK koja kodira protein u nekom pogodnom virusnom vektoru kao što je virus vakcinije.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HRP-129/91A HRP930512B1 (en) | 1990-01-26 | 1993-03-24 | Recombinant coccidiosis vaccines - 5-7 eimeria surface antigen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47050890A | 1990-01-26 | 1990-01-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU12991A true YU12991A (sh) | 1994-06-10 |
| YU48525B YU48525B (sh) | 1998-11-05 |
Family
ID=23867879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU12991A YU48525B (sh) | 1990-01-26 | 1991-01-25 | Protein, dnk koji kodira protein, rekombinantni vektor koji obuhvata dnk i postupak za proizovodnju proteina |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0439056B1 (sh) |
| JP (2) | JP3023997B2 (sh) |
| KR (2) | KR100197455B1 (sh) |
| AT (1) | ATE104349T1 (sh) |
| AU (1) | AU634335B2 (sh) |
| CA (1) | CA2034768A1 (sh) |
| DE (1) | DE69101646T2 (sh) |
| DK (1) | DK0439056T3 (sh) |
| ES (1) | ES2063383T3 (sh) |
| FI (1) | FI910398A (sh) |
| HR (1) | HRP930512B1 (sh) |
| HU (1) | HU211205B (sh) |
| IE (1) | IE65363B1 (sh) |
| IL (1) | IL97013A (sh) |
| MC (1) | MC2227A1 (sh) |
| NO (1) | NO303910B1 (sh) |
| NZ (1) | NZ236864A (sh) |
| PT (1) | PT96581B (sh) |
| SA (1) | SA91110265B1 (sh) |
| YU (1) | YU48525B (sh) |
| ZA (1) | ZA9010461B (sh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5403581A (en) * | 1991-07-12 | 1995-04-04 | Hoffmann-La Roche Inc. | Coccidiosis vaccines |
| US6008342A (en) * | 1991-07-12 | 1999-12-28 | Roche Vitamins Inc. | DNA encoding eimeria antigen |
| PT653489E (pt) * | 1993-11-12 | 2003-06-30 | Akzo Nobel Nv | Vacina contra a coccidiose em aves domesticas |
| ATE200029T1 (de) | 1995-06-07 | 2001-04-15 | Pfizer | In ovo impfung gegen coccidiose |
| SK282436B6 (sk) | 1995-06-07 | 2002-02-05 | Pfizer Inc. | Živé sporocysty alebo oocysty Eimeria alebo ich zmesi na výrobu očkovacej látky |
| EP0872486A1 (en) * | 1997-04-09 | 1998-10-21 | Akzo Nobel N.V. | Eimeria proteins as vaccines |
| US6627205B2 (en) | 1997-12-01 | 2003-09-30 | Pfizer Incorporated | Ovo vaccination against coccidiosis |
| US6680061B1 (en) | 1998-10-07 | 2004-01-20 | Theodorus Cornelis Schaap | Coccidiosis vaccines |
| US6984378B1 (en) | 1999-02-26 | 2006-01-10 | Pfizer, Inc. | Method for the purification, recovery, and sporulation of cysts and oocysts |
| ATE484573T1 (de) | 2001-08-30 | 2010-10-15 | Embrex Inc | Verbesserte verfahren zur herstellung von oozysten |
| JP3995541B2 (ja) * | 2002-06-28 | 2007-10-24 | 株式会社ゲン・コーポレーション | 抗鶏コクシジウム症組成物 |
| WO2004063339A2 (en) | 2003-01-08 | 2004-07-29 | Lesley Davenport | G-quadruplex binding assays and compounds therefor |
| KR100628023B1 (ko) | 2004-06-11 | 2006-09-26 | (주)넥스젠 | 콕시듐 원충의 포자소체의 재조합 표면항원 단백질 및이를 포함하는 콕시듐병 백신 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0135073A3 (en) * | 1983-08-19 | 1987-05-27 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against merozites of eimeria spp. |
| CA1340520C (en) * | 1984-06-05 | 1999-05-04 | Karel Z. Newman Jr. | Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix |
| ZA893740B (en) * | 1988-06-03 | 1990-02-28 | Hoffmann La Roche | Recombinant coccidiosis vaccines |
-
1990
- 1990-12-28 ZA ZA9010461A patent/ZA9010461B/xx unknown
-
1991
- 1991-01-17 AT AT91100502T patent/ATE104349T1/de not_active IP Right Cessation
- 1991-01-17 DE DE69101646T patent/DE69101646T2/de not_active Expired - Fee Related
- 1991-01-17 EP EP91100502A patent/EP0439056B1/en not_active Expired - Lifetime
- 1991-01-17 DK DK91100502.3T patent/DK0439056T3/da active
- 1991-01-17 ES ES91100502T patent/ES2063383T3/es not_active Expired - Lifetime
- 1991-01-23 NZ NZ236864A patent/NZ236864A/xx unknown
- 1991-01-23 HU HU91235A patent/HU211205B/hu not_active IP Right Cessation
- 1991-01-23 CA CA002034768A patent/CA2034768A1/en not_active Abandoned
- 1991-01-24 AU AU69952/91A patent/AU634335B2/en not_active Ceased
- 1991-01-24 IL IL97013A patent/IL97013A/xx not_active IP Right Cessation
- 1991-01-24 JP JP3022573A patent/JP3023997B2/ja not_active Expired - Fee Related
- 1991-01-24 MC MC912167A patent/MC2227A1/xx unknown
- 1991-01-24 NO NO910279A patent/NO303910B1/no not_active IP Right Cessation
- 1991-01-25 FI FI910398A patent/FI910398A/fi unknown
- 1991-01-25 KR KR1019910001306A patent/KR100197455B1/ko not_active IP Right Cessation
- 1991-01-25 IE IE27691A patent/IE65363B1/en not_active IP Right Cessation
- 1991-01-25 PT PT96581A patent/PT96581B/pt not_active IP Right Cessation
- 1991-01-25 YU YU12991A patent/YU48525B/sh unknown
- 1991-03-20 SA SA91110265A patent/SA91110265B1/ar unknown
-
1993
- 1993-03-24 HR HRP-129/91A patent/HRP930512B1/xx not_active IP Right Cessation
-
1998
- 1998-11-20 KR KR1019980049922A patent/KR100207354B1/ko not_active IP Right Cessation
-
1999
- 1999-11-19 JP JP33053299A patent/JP3215692B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cox et al. | Rabies virus glycoprotein. II. Biological and serological characterization | |
| YU12991A (sh) | Rekombinantne vakcine protiv kokcidioze-5-7 eimeria površinski antigen | |
| DK0835315T3 (da) | Vaccine til porcint reproduktivt og respiratorisk syndrom virus | |
| DK0612250T3 (da) | Fremgangsmåder og præparater med relation til nyttige Moraxella catarrhalis-antigener | |
| ATE85622T1 (de) | Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus. | |
| NO329875B1 (no) | Isolert DNA-sekvens som koder for svinereproduktive- og respiratoriske syndromvirus (PRRSV), en sammensetning omfattende polypeptidene kodet av denne, en sammensetning for indusering av antistoffer mot PRRSV, anvendelse av sammensetning for fremstilling av vaksine og fremgangsmate for a skille PRRSV-stamme ISU-55 fra andre PRRSV-stammer. | |
| CY1106175T1 (el) | Αλληλουχιες νουκλεϊνικου οξεος και αμινοξεος μολυσματικου ιου αναιμιας σολομων και χρηση τους ως εμβολια | |
| EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
| ATE126274T1 (de) | Rekombinanter impfstoff gegen marek's krankheit. | |
| DK43991A (da) | Allele varianter af plasmodium falciparum merozoitoverfladeantigen | |
| USED | Moscow VOPROSY VIRUSOLOGII in Russian No 1, Jan-Feb 82 (manuscript received 25 Feb 81) pp 5-11 [Article by VI Kostyukov, AI Yarov and Ye. G. Zezerov][Text] Live and killed vaccines are used extensively in current specific prevention of viral infections. In many cases, the use of a number of vaccines | |
| GB2244273A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. | |
| TH62970A (th) | วัคซีนไวรัสโรคเบอร์ซาอักเสบติดต่อชนิดบรอดสเปคตรัม (broad spectrum) |